Hepatocyte growth factor (HGF) is a potent antifibrotic protein that inhibits kidney fibrosis through several mechanisms. To study its role in podocyte homeostasis, injury, and repair in vivo, we generated conditional knockout mice in which the HGF receptor, c-met, was specifically deleted in podocytes using the Cre-LoxP system. Mice with podocyte-specific ablation of c-met (podo-met À/À ) developed normally. No albuminuria or overt pathologic lesions were detected up to 6 months of age, suggesting that HGF signaling is dispensable for podocyte maturation, survival, and function under normal physiologic conditions. However, after adriamycin treatment, podo-met À/À mice developed more severe podocyte injury and albuminuria than their control littermates. Ablation of c-met also resulted in more profound suppression of Wilms tumor 1 (WT1) and nephrin expression, and podocyte apoptosis after injury. When HGF was expressed ectopically in vivo, it ameliorated adriamycininduced albuminuria, preserved WT1 and nephrin expression, and inhibited podocyte apoptosis. However, exogenous HGF failed to significantly reduce albuminuria in podo-met À/À mice, suggesting that podocyte-specific c-met activation by HGF confers renal protection. In vitro, HGF was able to preserve WT1 and nephrin expression in cultured podocytes after adriamycin treatment. HGF also protected podocytes from apoptosis induced by a lethal dose of adriamycin primarily through a phosphoinositide 3-kinase (PI3K)/Aktdependent pathway. Collectively, these results indicate that HGF/c-met signaling has an important role in protecting podocytes from injury, thereby reducing proteinuria.
Hepatocyte growth factor (HGF) is a pleiotropic protein that has an important role in the regulation of organ development, tissue homeostasis, injury repair, and regeneration. 1, 2 Extensive studies have demonstrated that HGF is also a potent antifibrotic factor that prevents the onset and progression of a wide variety of chronic kidney diseases, including diabetic nephropathy, obstructive nephropathy, remnant kidney after 5/6 renal ablation, and chronic allograft nephropathy. [3] [4] [5] [6] [7] Interestingly, administration of HGF protein or its gene seems particularly effective in ameliorating proteinuric kidney diseases, 8, 9 in which podocyte dysfunction and/or depletion are thought to have a causative role. [10] [11] [12] These observations suggest a possible linkage of HGF signaling to podocyte function under physiological and pathological conditions. However, the function of HGF in podocyte maturation, survival, and differentiation in vivo in normal physiologic setting remains poorly understood. Furthermore, very little is known about the role of HGF in regulating podocyte dysfunction and survival in vivo after a variety of insults.
Podocytes are specialized, terminally differentiated visceral epithelial cells that reside on the glomerular basement membrane outside the glomerular capillaries. 13 These cells possess unique, sophisticated foot processes, and slit diaphragm, a membrane-like structure that is one of the principal components of the glomerular filtration barrier. 14 Not surprisingly, disruption of podocyte integrity will lead to development of proteinuria and glomerulosclerosis. Depending on the severity and duration of injury, podocytes respond to various injurious stimuli in different ways, including dedifferentiation, detachment, and apoptosis. 15, 16 Emerging evidence indicates that podocytes also undergo epithelial-tomesenchymal transition after injury by losing their unique features and acquiring mesenchymal markers. 17, 18 In view of the ability of HGF in regulating epithelial-to-mesenchymal transition and cell survival, 5, 19 it is plausible to speculate that HGF could have a role in preserving podocyte structure and function after injury, thereby preventing the development of proteinuria.
The biological activities of HGF are mediated by a single receptor, c-met, which belongs to a family of the transmembrane tyrosine kinase receptors that transmit growth factor signals across the plasma membrane by activating multiple downstream signaling events. 1, 20 Although HGF expression is limited to nonepithelial cells in the kidney, such as fibroblasts, mesangial cells, and endothelial cells, c-met protein is ubiquitously expressed in almost all types of cells. 21 Podocytes in normal glomeruli are shown to express c-met protein, 21 suggesting that these cells are capable of responding to HGF stimulation.
To elucidate the role of HGF/c-met signaling in podocyte homeostasis and injury/repair in vivo, here we have generated conditional knockout mice in which c-met is specifically ablated in podocytes by using Cre-LoxP recombination system. We show that mice with podocyte-specific deletion of c-met are healthy but develop more severe albuminuria, podocyte lesions, and podocyte loss after injury. In addition, ectopic expression of exogenous HGF ameliorates podocyte dysfunction and apoptosis and reduces proteinuria. Our findings suggest that HGF/c-met signaling is critical for preventing podocyte injury and proteinuria in pathological conditions.
RESULTS

Mice with podocyte-specific ablation of c-met are healthy
To explore the role of HGF/c-met signaling in podocyte homeostasis in vivo, we generated conditional knockout mice in which c-met gene was specifically disrupted in glomerular podocytes by using the Cre-LoxP system ( Figure 1a) . . Western blot analysis demonstrated that c-met protein level was reduced in the isolated glomeruli from podo-met À/À mice, compared with those from control podomet þ / þ littermates ( Figure 1c) . Notably, the faint c-met protein band seen in the western blot analysis of podo-met À/À mice ( Figure 1c ) was probably derived from the nonpodocyte glomerular cells, as both mesangial and endothelial cells express c-met protein. There was no difference in body weight, kidney/body weight ratio, and urine albumin level between podo-met À/À mice and their control littermates at 3 and 6 months after birth, respectively (Figure 1d-f) . Podocyte numbers and density as shown by Wilms tumor 1 (WT1) staining were similar in podo-met À/À mice and their control littermates. Furthermore, there was no alteration in major slit-diaphragm protein, nephrin, expression and distribution in the glomeruli of podo-met À/À mice, in comparison with the control littermates. Electron microscopy showed an intact ultrastructure of the glomerular filtration barrier in podomet À/À mice (see below). Together, these results demonstrate that HGF/c-met signaling seems dispensable for podocyte maturation, survival, and function under normal physiologic conditions in vivo.
Ablation of c-met aggravates albuminuria and exacerbates WT1 and nephrin loss after adriamycin injury Next, we investigated the role of HGF/c-met signaling in podocyte injury under pathological conditions by challenging podo-met À/À mice with adriamycin (ADR), an agent that specifically damages glomerular podocytes. 22 As shown in Figure 2 , mice developed albuminuria at day 1 and 3, respectively, after intravenous injection of ADR at a dose of 25 mg/kg body weight. Under same conditions, podo-met À/À mice developed more severe albuminuria at day 3, compared with the control littermates. Sodium dodecyl sulfate-polyacrylamine gel electrophoresis analysis of urine samples after normalization to urinary creatinine revealed that albumin We further examined the expression of WT1, a nuclear zinc finger-containing transcription factor, that is a molecular signature of podocytes and has an essential role in establishing the podocyte-specific gene expression in adult kidney. 23, 24 As shown in Figure 3a and b, ADR caused a significant decrease in the number of the WT1-positive cells in the glomeruli of podo-met þ / þ mice. Ablation of c-met, however, markedly exacerbated WT1 loss after ADR injury (Figure 3a and b) . Notably, ablation of c-met not only reduced the number of WT1-positive cells after ADR injury, but also significantly decreased the level of WT1 in the positively stained podocytes (Figure 3a, arrowheads) , suggesting the pivotal role of HGF/c-met signaling in preserving WT1 expression in vivo.
Immunofluorescent staining revealed that levels of nephrin were reduced and its distribution was changed from a linear to granular pattern in control podo-met þ / þ mice after ADR injury ( Figure 3a) . As illustrated in the enlarged boxed area, nephrin staining in normal glomeruli exhibited a typical, fine line pattern in the podocytes (Figure 3a @ , arrow). The ADR-caused injury not only reduced the overall abundance of nephrin protein, but also converted its linear staining into a disorganized, scattered, and granular pattern (Figure 3a *, arrow). These lesions in nephrin expression and distribution were more severe in podo-met À/À mice after ADR injury, compared with the control littermates (Figure 3a and c). We also examined the ultrastructure of podocyte foot processes and slit diaphragm by electron microscopy. As shown in Figure 3d , foot process effacement was evident and slit diaphragm disappeared in some area of the glomeruli in podo-met þ / þ mice after ADR injection. More severe lesions in the foot processes and slit diaphragm, however, were observed in podo-met À/À mice under the same conditions (Figure 3d ).
Ablation of c-met promotes podocyte apoptosis after injury
In view of a decrease in the WT1-positive cells in the glomeruli after ADR injury, we next examined whether podocytes undergo apoptosis. Immunohistochemical staining for the cleaved caspase-3 revealed that apoptosis was extremely rare in mice at day 3 after injection of ADR (Figure 4) , a time point when significant albuminuria developed ( Figure 2 ). Quantitative determination of apoptotic cells showed about two apoptotic cells among every 100 glomerular cross-sections (Figure 4e ). Judged from their localization in the glomeruli, these apoptotic cells appeared to be podocytes (Figure 4c ). Interestingly, ablation of c-met in a podocyte-specific manner increased the numbers of apoptotic cells in the glomeruli after ADR injection (Figure 4d and e), suggesting that HGF/c-met signaling has an important role in podocyte survival after injury.
Expression of exogenous HGF in mice ameliorates podocyte injury and albuminuria
To confirm the protective role of HGF/c-met signaling in preserving podocyte function, we sought to evaluate the effect of exogenous HGF on proteinuric nephropathy in mice. To this end, BALB/c mice were injected intravenously with HGF expression plasmid (pCMV-HGF) or empty vector (pcDNA3) by using a hydrodynamic-based gene delivery approach. Notably, this method produced substantial exogenous HGF in kidney glomeruli and in circulation, as previously reported. 8, 25, 26 To ascertain that glomerular podocytes respond to exogenous HGF, we examined the activation of extracellular signal-regulated kinase-1/2 (Erk-1/2), a major downstream mediator of HGF signaling. As shown in Figure 5 , HGF plasmid injection induced a marked phosphorylation of Erk-1/2 in mouse glomeruli. Double immunostaining revealed that phospho-specific Erk-1/2 was largely colocalized with nephrin, suggesting a podocytespecific response to exogenous HGF expression. We administrated ADR (10 mg/kg body weight) into BALB/c mice at 16 h after HGF plasmid injection (Figure 5a ). Heavy albuminuria developed in mice at day 3 and day 4 after ADR injection (Figure 5c ). Interestingly, delivery of exogenous HGF gene markedly ameliorated ADR-induced albuminuria in these mice (Figure 5c ). Consistent with the albuminuria data, exogenous HGF expression also prevented a reduction of WT1 and nephrin expression induced by ADR. As shown in Figure 5d and e, ADR caused significant loss of WT1 expression in glomerular podocytes; and HGF expression almost completely preserved WT1 protein expression. Similarly, exogenous HGF also preserved nephrin expression and its distribution in podocytes after ADR injury (Figure 5d and f).
To assess whether the beneficial effect of exogenous HGF is directly related to c-met activation in podocytes, we examined the reno-protective role of exogenous HGF in podo-met À/À mice after ADR injury. As shown in Figure 5g , although ectopic expression of exogenous HGF reduced albuminuria in podo-met þ / þ mice after ADR injection, it did not significantly affect albuminuria in podo-met À/À mice in which c-met was specifically ablated in podocytes, suggesting a direct and predominant role of podocytespecific c-met signaling in conferring HGF renoprotection after ADR injury. Figure 6 shows the effect of exogenous HGF on podocyte apoptosis induced by ADR. Glomerular cell apoptosis was also detectable, albeit extremely rare, in BALB/c mice after ADR injection. The incidence of apoptosis was about two cells per 100 glomerular cross-sections (Figure 6d ). Delivery of exogenous HGF gene almost completely prevented glomerular cells from apoptosis induced by ADR in vivo (Figure 6c and d) .
HGF preserves WT1 and nephrin expression in podocytes after injury in vitro
To further investigate HGF protection of podocytes from injury, we used cultured mouse podocytes as an in vitro system. As shown in Figure 7a and b, incubation of mouse podocytes with a sub-lethal dose of ADR (2 mg/ml) for 16 h markedly downregulated WT1 protein expression. Although HGF alone had little effect on WT1 expression, simultaneous incubation with it largely preserved WT1 protein expression after ADR treatment in a dose-dependent manner (Figure 7a  and b) .
We then examined the expression of nephrin, a major slit diaphragm-associated protein, which is a direct transcriptional target of WT1. 27, 28 In cultured podocytes, nephrin mRNA expression was suppressed after ADR treatment (Figure 7c and d) . HGF alone seemed to have the tendency to slightly downregulate nephrin mRNA expression. Simultaneous incubation with HGF, however, clearly preserved nephrin mRNA expression in ADR-treated podocytes (Figure 7c and d) .
HGF prevents podocyte apoptosis after injury in vitro
We also examined the ability of HGF in protecting podocytes from apoptosis after injury in vitro. When mouse podocytes were incubated with a lethal dose of ADR (20 mg/ml), these cells underwent apoptosis in a time-dependent manner, characterized by caspase-3 cleavage and activation (Figure 8a) . Treatment of the cells with HGF largely prevented caspase-3 cleavage induced by ADR. The antiapoptotic activity of HGF was also dose dependent ( Figure 8b ). Similar pro-survival action of HGF was found in cultured human podocytes as well (Figure 8c and d) . Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling and immunostaining for cleaved caspase-3 also confirmed the cytoprotective ability of HGF in podocytes after a lethal dose of ADR ( Figure 9 ).
We next investigated the potential signal pathway leading to HGF protection of podocytes. As shown in Figure 10a and b, HGF markedly and rapidly activated protein kinase B/ Akt and mitogen-activated protein kinase Erk-1/2 phosphorylation and activation. Incubation with wortmannin, a specific inhibitor of Akt upstream phosphoinositide 3-kinase (PI3K), or PD98058, a specific inhibitor of Erk-1/2 upstream Mek1, blocked Akt and Erk-1/2 phosphorylation, respectively (Figure 10a and b) . As shown in Figure 10c and d, blockade of Akt activation by wortmannin, but not Erk-1/2 activation by PD98059, abolished the ability of HGF to prevent podocyte apoptosis induced by ADR, suggesting that HGF promotes podocyte survival through a PI3K/Akt-dependent pathway.
DISCUSSION
Podocyte dysfunction and depletion are increasingly recognized as causative events in the pathogenesis of proteinuria and glomerulosclerosis in many common forms of proteinuric kidney diseases, such as diabetic nephropathy and focal and segmental glomerulosclerosis. 10, 16, 29 In this context, identification of crucial factors that regulate podocyte survival, differentiation, function, and injury/repair will be of vital importance in understanding the mechanism underlying the onset of proteinuria, and in exploring new therapeutic strategies. In this study, we demonstrate that HGF/c-met signaling has a critical role in preventing podocyte injury under pathologic conditions. The ablation of HGF signaling in podocytes by conditional knockout of its c-met receptor renders the mice more susceptible to ADR-induced podocyte injury, resulting in more severe albuminuria. Conversely, ectopic expression of exogenous HGF gene in mice protects podocytes and ameliorates albuminuria in ADR nephropathy. Our findings clearly establish that HGF/c-met signaling is cytoprotective in preventing podocyte dysfunction and apoptosis in diseased kidney. Despite its expression in podocytes, knockout of c-met receptor in mice does not result in any overt abnormality in glomerular structure and function. This suggests that HGF signaling is dispensable for podocyte maturation, survival, and function under physiological conditions. Given the functional redundancy of many peptide growth factors in vivo, 30 it is not completely surprising that mice with podocyte-specific deletion of c-met receptor have normal phenotype, with no effect on body and kidney growth, and on kidney function. This finding is compatible with previous observation in liver, in which knockout of c-met receptor specifically in hepatocytes does not cause any detrimental effect under physiological conditions. 31 It is worthwhile to point out that the Cre recombinase driven under podocin promoter begins to express in podocytes during late capillary loop stage of glomerular development in the newborn mice. 32 Therefore, it remains to be determined whether HGF/c-met signaling has a role in mediating the initial differentiation of podocytes during early kidney development.
This study provides a clear in vivo evidence for a critical role of HGF/c-met signaling in preventing podocyte dysfunction and apoptosis after injury. Both loss-and gainof-function strategies indicate that HGF specifically acts on podocytes to protect against dedifferentiation and apoptosis triggered by injurious stimuli. Although recent studies point to alterations in glomerular endothelium at 6 days after ADR injection, 33 the cause-effect relationship of these endothelial lesions with proteinuria remains uncertain in this model. Podocyte dysfunction occurs early in ADR nephropathy, 34 in which albuminuria is eminent in 1-3 days (Figure 2) . Indeed, exogenous HGF only ameliorates albuminuria in podomet þ / þ mice, but not in podo-met À/À mice (Figure 5g ), supporting a direct and predominant role of podocytespecific c-met activation in conferring HGF renoprotection against albuminuria in this model. Adriamycin is well known to specifically damage podocytes in the glomeruli and to trigger kidney lesions characterized by proteinuria and glomerulosclerosis, 22 though its pathogenic mechanism in vivo remains poorly understood. We show here that ADR induces WT1 and nephrin loss in vivo, suggesting that podocyte dedifferentiation could be attributable to the development of albuminuria. Given that podocyte apoptosis is an extremely rare event (Figure 4) , it seems unlikely that podocyte depletion is the initial cause that results in the onset of albuminuria in this model. In this context, downregulation of WT1 gene and suppression of nephrin expression seem to be two major pathogenic alterations in glomerular podocytes in vivo after ADR administration that undoubtedly leads to podocyte dysfunction. Indeed, low dose of ADR (2 mg/ml) also suppresses both WT1 and nephrin expression in cultured mouse podocytes in vitro (Figure 7) . The observation that HGF preserves WT1 and nephrin in podocytes both in vivo and in vitro suggests that this signaling is able to specifically target the key pathogenic events in ADR nephropathy. Notably, in addition to a reduced mRNA expression, nephrin loss could also result from a shedding of its protein from the cell surface due to protease-mediated cleavage and cytoskeleton redistribution. 35 It remains to be determined whether HGF also protects podocytes from nephrin shedding after injury.
WT1 is a key transcription factor that has an essential role in early kidney development. In adult kidney, WT1 expression is restricted to mature podocytes, and is thought to be crucial in trans-activating multiple podocyte-specific genes, including nephrin and podocalyxin. Along this line, downregulation of WT1 expression by ADR could be an important pathway leading to suppression of podocytespecific genes, thereby causing podocyte dysfunction and the onset of proteinuria. This idea is substantiated by the observation that nephrin is downregulated in podocytes by ADR. It should be pointed out that HGF alone seems to have the tendency to inhibit nephrin expression in cultured podocytes (Figure 7 ), consistent with a previous report. 36 However, this slight inhibition of nephrin expression by HGF treatment alone in cultured podocytes in vitro is unlikely relevant to physiological conditions in vivo, as previous studies show that sustained expression of exogenous HGF for a long period of time (8 weeks) in mice does not cause any impairment of glomerular filtration and kidney function. 37 Importantly, concomitant incubation with HGF and ADR, a situation that closely resembles HGF administration in the pathological setting, is able to upregulate and preserve nephrin expression.
Severe and/or sustained injury undoubtedly causes podocyte apoptosis that eventually leads to podocyte depletion and glomerulosclerosis in the kidney. 16, 38 Studies in animal models have established that podocyte numbers and density have a decisive role in the genesis of proteinuria and glomerulosclerosis. 12, 38 In that regard, the ability of HGF in promoting cell survival could also have a role in protecting podocyte after injury. 39, 40 Indeed, this study demonstrates that HGF is able to protect cultured podocytes against apoptosis induced by a lethal dose of ADR (20 mg/ml), a concentration that is 10-fold higher than that induces podocyte dedifferentiation, as manifested by WT1 and nephrin suppression. Even at that high concentration of ADR, HGF is able to protect podocytes from undergoing apoptotic cell death, as evidenced by caspas-3 activation and terminal deoxynucleotidyl transferase-mediated dUTP nickend labeling staining. This cytoprotective effect of HGF against lethal dose of ADR is largely mediated by PI3K/Akt pathway, as blockade of Akt activation, but not of Erk-1/2, abolishes the ability of HGF to inhibit caspase-3 activation in podocytes. Notably, HGF seems to be more potent in protecting human podocytes from apoptosis induced by ADR, in comparison with their mouse counterparts (Figure 8 ). This probably reflects that human HGF preferentially works on human podocytes, despite a high degree of homology between human and mouse HGF proteins. 41 Accordingly, as the HGF gene injected into mice is of human origin, the effects of exogenous HGF in vivo are probably underestimated in this study.
In summary, we have demonstrated that HGF/c-met signaling has an important role in protecting podocytes from injury. HGF not only prevents podocytes from dedifferentiation and dysfunction after sublethal injury, but also protects podocytes against apoptosis after more severe insult. Our studies suggest that protection of podocyte from injury and depletion by exogenous HGF could be an effective way to prevent proteinuria and glomerulosclerosis under pathological conditions. 
MATERIALS AND METHODS
Generation of the podocyte-specific c-met knockout mice and genotyping The c-met-floxed mice were created by homologous recombination using a c-met gene fragment with loxP sites flanking exon 16, as described previously, 31, 42 and kindly provided by Dr Snorri S. Thorgeirsson (National Cancer Institute, NIH, Bethesda, MD, USA). Transgenic mice expressing Cre recombinase under the control of a 2.5-kb fragment of the human podocin promoter (2.5P-Cre mice) are reported elsewhere. 32 By mating c-met-floxed mice with podocin-Cre transgenic mice, mice that were heterozygous for the c-met-floxed allele were generated (genotype: c-met
). These mice were crossbred to inactivate both c-met alleles by Cre-mediated excision, thereby creating conditional knockout mice in which c-met gene was specifically disrupted in glomerular podocytes (genotype: c-met fl/fl , Cre þ /À ). The breeding protocol also generated heterozygous littermates (genotype: c-met
and wild type and several groups with different genotypes (c-met
). Polymerase chain reaction was used for c-met loxP and Cre genotyping. All mice with ages between 1-3 months were used in the study except otherwise Animal models of podocyte injury and proteinuria Mouse model for podocyte injury and proteinuria was established by intravenous injection of ADR. 22 Different genetic backgrounds and strains of mice displayed significant divergences in response to ADR injury. All transgenic mice with C57BL/6J or mixed back- grounds were injected with a high dose of ADR protocol (25 mg/kg body weight), 34 whereas BALB/c mice were sensitive to and only received a low dose of the drug (10 mg/kg body weight). Briefly, podo-met À/À mice and their control podo-met þ / þ littermates were injected with ADR (doxorubicin hydrochloride; Sigma, St Louis, MO, USA) at the dosage of 25 mg/kg body weight in saline solution through tail vein. All male BALB/c mice weighing 20-22 g were obtained from Harlan Sprague-Dawley (Indianapolis, IN, USA), and injected through the tail vein with ADR at 10 mg/kg body weight. At different time points after ADR injection, mice were killed. Urine, kidney tissue and glomeruli were collected. For introducing exogenous HGF in vivo, mice were administrated with HGF expression plasmid (pCMV-HGF) at 1 mg/kg by a hydrodynamicbased gene transfer technique through rapid injection of a large volume of DNA solution through the tail vein, as described previously. 8, 25, 37 At 16 h after plasmid injection, mice were injected with ADR through tail vein, and killed at day 4. Urine and kidney samples were collected. Mouse backgrounds and ADR protocol used in this study are listed in Table 1 .
Urinary albumin and creatinine assay Urine albumin level was measured by using a mouse Albumin ELISA Quantification kit, according to the manufacturer's protocol (Bethyl Laboratories, Montgomery, TX, USA). Urine creatinine was determined by a routine procedure as described previously. 43 Urinary proteins were also analyzed by sodium dodecyl sulfatepolyacrylamine gel electrophoresis after normalization to urinary creatinine. After separation by sodium dodecyl sulfate-polyacrylamine gel electrophoresis, urine proteins were stained with Coomassie blue R-250.
Immunofluorescent staining and confocal microscopy Kidney cryosections were fixed with 3.7% paraformalin for 15 min at room temperature. After blocking with 10% donkey serum for 30 min, slides were immunostained with primary antibodies against phospho-specific Erk-1/2 (Thr202/Tyr204; cat. no. 4370; Cell Signaling Technology, Danvers, MA, USA) and nephrin (Progen, Heidelberg, Germany), respectively. Slides were viewed under a Leica TCS-SL confocal microscope (Bannockburn, IL, USA). 43 For determination of the podocyte injury, as defined by nephrin loss and altered distribution, a semiquantitative scoring method was used. Score 0 represents no lesion, whereas 1, 2, 3, and 4 represent the nephrin loss and altered distribution, involving o25%, 25-50%, 50-75%, and 475% of the glomerular tuft area, respectively. At least five randomly chosen glomeruli were evaluated for each mouse and an average composite score was calculated. Paraffin-embedded mouse kidney sections (3 mm thickness) were prepared by a routine procedure. Immunohistochemical staining for WT1 (sc-192; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and cleaved caspase-3 (cat. no. 9661; Cell Signaling Technology) was performed using a routine protocol as described previously. 43, 44 Glomerular isolation Glomerular isolation was performed according to the method described elsewhere. 43, 45 Briefly, mice were anesthetized by intraperitoneal injection of pentobarbital (50 mg/kg) and perfused, through the abdominal artery, with 8 Â 10 7 Dynabeads M-450 (Dynal Biotech ASA, Oslo, Norway) diluted in 5 ml of phosphate buffered saline. After perfusion, the kidneys were removed and cut into 1-mm 3 pieces and digested in collagenase A (1 mg/ml) at 37 1C for 30 min with gentle shaking. The tissue was then pressed gently through a 100-mm cell strainer (BD Falcon, Bedford, MA, USA). Glomeruli-containing Dynabeads were then gathered by using a magnetic particle concentrator. The isolated glomeruli were washed three times with cold phosphate buffered saline and used for subsequent studies. The purity of the isolated glomeruli reached to more than 95% by this method.
Western blot analysis
The isolated glomeruli were pooled and lysed with radioimmunoprecipitation assay buffer containing 1% NP-40, 0.1% sodium dodecyl sulfate, 100 mg/ml phenylmethylsulfonyl fluoride, 1% protease inhibitor cocktail, and 1% phosphatase I and II inhibitor cocktail (Sigma) in phosphate buffered saline on ice. The supernatants were collected after centrifugation at 13,000 Â g at 4 1C for 20 min. Cultured podocytes were lysed in sodium dodecyl sulfate sample buffer. Protein expression was detected by western blot analysis as described previously. 43 The primary antibodies used were as follows: anti-WT1 (Santa Cruz Biotechnology); anti-c-met (cat. no. 3127), anti-cleaved caspase-3, anti-phospho-specific Akt (Ser473; cat no. 4060) and total Akt (cat. no. 9272), anti-phopshospecific Erk-1/2 (cat. no. 4370;Cell Signaling Technology); antiglyceraldehyde-3-phosphate dehydrogenase (cat. no. 4300; Ambion), anti-procaspase-3 (sc-7148; Santa Cruz Biotechnology), and anti-atubulin (cat. no. T9026; Sigma).
Electron microscopy
Electron microscopy of kidney samples was carried out by routine procedures as described previously. 43 Briefly, mouse kidneys were perfusion fixed with 2.5% glutaraldehyde in phosphate buffered saline by left cardiac ventricular injection and post-fixed in aqueous 1% OsO 4 . Specimens were dehydrated through an ethanol series, infiltrated in a 1:1 mixture of propylene oxide/Polybed 812 epoxy resin (Polysciences, Warrington, PA, USA), and then embedded. Ultrathin sections were stained with 2% uranyl acetate, followed by 1% lead citrate. Sections were observed and photographed using a JEOL JEM 1210 transmission electron microscope (Peabody, MA, USA).
Cell culture and treatment
The conditionally immortalized mouse podocyte cell line was kindly provided by Dr Peter Mundel (Mount Sinai School of Medicine, New York, NY, USA) and described previously. 46 Immortalized human podocytes were described previously. 47 Cells were cultured at 33 1C in RPMI-1640 medium supplemented with 10% fetal bovine serum and recombinant interferon-g (Invitrogen, Carlsbad, CA, USA). To induce differentiation, podocytes were grown under nonpermissive conditions at 37 1C in the absence of interferon-g. After serum starvation for 16 h, cells were treated with ADR in the absence or presence of human recombinant HGF (R&D Systems, Minneapolis, MN, USA) for various periods of time as indicated. In some experiments, cells were pretreated with either various inhibitors at given concentrations or vehicle (0.1% dimethylsulfoxide) 0.5 h before incubation with HGF. Wortmannin (PI3K inhibitor) and PD98059 (Mek1 inhibitor) were purchased from Calbiochem (La Jolla, CA, USA).
RNA extraction and reverse transcriptase-PCR
For determination of nephrin mRNA expression, a semi-quantitative reverse transcriptase-PCR was used. Total RNA isolation and reverse transcriptase-PCR amplification of nephrin mRNA were carried out using the procedures described previously. 17 Briefly, the first-strand complementary DNA synthesis was carried out using a Reverse Transcription System kit, according to the instructions of the manufacturer (Promega, Madison, WI, USA). Polymerase chain reaction amplification was performed using HotStar Taq Master Mix Kit (Qiagen, Valencia, CA, USA). The sequences of nephrin and b-actin primer pairs have been described previously. 17 After quantifying bands using densitometry, the relative steady-state level of mRNA was calculated and compared after normalizing to b-actin.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining Apoptotic cell death was determined using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining using Apoptosis Detection System (Promega), as previously reported. 43 Statistical analyses Statistical analysis of the data was performed using SigmaStat software (Jandel Scientific, San Rafael, CA, USA). Comparison between groups was made using one-way analysis of variance, followed by the Student-Newman-Keuls test. Po0.05 was considered statistically significant.
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